{
  "file_id": "file_eaf554e26406",
  "source_path": "C:\\IntelliCV\\data\\resume_versions\\uploads\\61403 Roghaiyeh Safari\\Roghaiyeh Safari 24112020 (1) (2) 61403.pdf",
  "extracted_at": "2025-08-10T16:27:21.375902",
  "text": " \n   \n \nROGHAIYEH SAFARI  \n \nProject manager/  Senior scientist/ Scientific writer  \n \nGSM: +32 494 19 35 83  \nEMAIL:  roghaiyeh.safari@gmail.com  \nSOFT SKILLS  \n• Leader – a coach  \n• Excellent communicator  \n• Team Builder  \n• Keen decision Maker  \n• Well organized  \n• Problem solver  \nLANGUAGE  \n• English ( fluent)  \n• French (B1)  \n• Dutch(A1)  \n• Azerbaijani (maternal)  \n• Turkish ( fluent)  \n• Persian ( fluent)  \nIT SKILLS  \n• R, Rstudio  \n• RNA seq uencing  data   analyzing  \n(STA R, feauture counts, Deseq2, \nGSEA, igraph, \nvennDiagram,Pheatmap,)  \n• Data visualization  \n• SPSS  \nKEY SUCCESS  IN SCIENCE  \n•Establishment of multiple drug resistant \ncell lines (lung cancer)  \n• Establishment of cell lines using \nprimary cells (lung cancer and virus \ninfected spleen cells)  \n• Establis  \n   \n \nROGHAIYEH SAFARI  \n \nProject manager/  Senior scientist/ Scientific writer  \n \nGSM: +32 494 19 35 83  \nEMAIL:  roghaiyeh.safari@gmail.com  \nSOFT SKILLS  \n• Leader – a coach  \n• Excellent communicator  \n• Team Builder  \n• Keen decision Maker  \n• Well organized  \n• Problem solver  \nLANGUAGE  \n• English ( fluent)  \n• French (B1)  \n• Dutch(A1)  \n• Azerbaijani (maternal)  \n• Turkish ( fluent)  \n• Persian ( fluent)  \nIT SKILLS  \n• R, Rstudio  \n• RNA seq uencing  data   analyzing  \n(STA R, feauture counts, Deseq2, \nGSEA, igraph, \nvennDiagram,Pheatmap,)  \n• Data visualization  \n• SPSS  \nKEY SUCCESS  IN SCIENCE  \n•Establishment of multiple drug resistant \ncell lines (lung cancer)  \n• Establishment of cell lines using \nprimary cells (lung cancer and virus \ninfected spleen cells)  \n• Establishment of animal model (lung \ncancer, bovine leukemia virus)  \n• Establishment of cell lines with \ndifferent mutation using lentivirus  \nvectors  \n• Successful transduction of primary \nimmune  cells (B/T lymphocyte, \nmacrophages)   \nEDUCATION  \nDokuz Eylul University, Izmir, Turkey                              2013  \nPh.D., Molecular Medicine GPA: 3.66/4  \n  \nTabriz Medical Sciences University, Tabriz, IRAN               2002  \nMaster of Science, Midwifery with orientation Maternal and Child Health    \nGPA: 3.84/4 (honor awards)  \n \nTabriz Medical Sciences University, Tabriz, IRAN            1996  \nBachelor of Science (B.S.), Midwifery GPA: 3.79/4 (honor awards)  \n \nWORK EXPERIENCE   \n \nProject manager/ Senior scientist                                           2020 -present  \nBiogazelle, Zwijnaarde, Belgium  \nManagement of Clinical trials, Research & Development (R&D), and funding \nprojects.  \n \nProject manager                                                                          2018 -2020     \nTERRA , Gembloux,  Belgium                                                                                          \n  \nVaccine and drug developer, researcher                              2016 -2018 \nLiege University, Liege,  Belgium  \nBovine leukemia virus, Human T lymphocyte \nleukemia virus, Mesothelioma  \n \nDrug and biomarker developer, researcher                        2013 -2016  \nIzmir Biomedicine & Genome Center (iBG - Izmir), Izmir, Turkey  \nLung cancer, H uman brain cancer  \n \nResearcher                                                                                2012 -2013  \nSahlgrenska Cancer Center, Gothenburg University, Gothenburg, Sweden  \nMelanoma, Cardiomyopathy  \n \nManagement of a midwifery clinic and Midwife              1998 -2010  \nTabriz, Iran  \n \nLecturer                                                                                       2003 -2005  \nMarand Azad university     \n \nMidwife and maternal health provider                                1996 -1998  \nMinistry of health, Bahshayesh  \n  \n \n\n \n \nPUBLICATIONS   \nSafari R , …Trono K, Willems L. BLV:  lessons on vaccine development.  Retrovirology. 2019 Oct 7;16(1):26. doi: \n10.1186/s12977 -019-0488 -8. \n \nSafari R  , Jacques JR, Brostaux Y,  Willems L.  Ablation of non -coding RNAs affects bovine leukemia virus B lymphocyte \nproliferation and abrogates oncogenesis. plos pathogen, Published: May 14, \n2020https://doi.org/10.1371/journal.ppat.1008502  \n \nStaumont B, Costa C, Vandermeers F, Sriramareddy SN, Redouté G,  Mascaux C, Delvenne P, Hubert P, Allaer D, Safari R , \nWillems. Combined EGFR -HDAC inhibition overcomes resistance to malignant pleural mesothelioma anthracycline \nsecond -line chemotherapy. Submitted to oncogene \n \nSafari R , Redout é G, Willems Luc. Cytotoxic activity of biosourced astins against malignant pleural mesothelioma cells. \nManuscript under preparation  \n \nGazon H, Chauhan P, Hamaidia M, Hoyos C, Li L, Safari R , Willems L. How Does HTLV -1 Undergo Oncogene -Dependent \nReplicatio n Despite a Strong Immune Response? Front Microbiol. 2018 Jan 15;8:2684. doi: \n10.3389/fmicb.2017.02684. eCollection 2017.  \n  \nSafari R , Hamaidia M, de Brogniez  A, Gillet N, Willems L. Cis -drivers and trans -drivers of bovine leukemia virus \noncogenesis. Curr Opin Virol. 2017 Oct;26:15 -19. doi: 10.1016/j.coviro.2017.06.012. Epub 2017 Jul 25.  \n  \nSafari R , ",
  "emails": [
    "roghaiyeh.safari@gmail.com"
  ],
  "phones": [
    "2017.02684",
    "0219635216500096",
    "1-49392297"
  ],
  "names": [
    "Cardiovasc Res",
    "Newly Synthesized",
    "Methods Mol"
  ],
  "work_history": [],
  "title": "",
  "company": "",
  "location": "",
  "experience_years": 0,
  "career_stage": "entry",
  "industries": [
    "general"
  ],
  "skills": [],
  "ai_scores": {
    "experience_years": 0.0,
    "title_progression": 0.5,
    "company_prestige": 0.5,
    "location_mobility": 0.5,
    "skill_diversity": 0.0,
    "network_strength": 0.3
  },
  "ai_final_score": 0.27,
  "ai_processed_at": "2025-08-11T10:42:14.870915",
  "similar_users": [
    {
      "user_id": "file_0003865a7c4a",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_000a12cbb771",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_00344b0836c2",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_0086ec6f1b90",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_008dcceee73c",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_00e4daf72a60",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_00f1ad8aa85c",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_00f585667d18",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_010f7e646664",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    },
    {
      "user_id": "file_012ae853275f",
      "similarity_score": 1.0,
      "career_stage": "entry",
      "industries": [
        "general"
      ],
      "ai_score": 0.27,
      "experience_years": 0
    }
  ],
  "recommendations": {
    "career_advancement": [
      "Focus on building core technical skills",
      "Seek mentorship from senior team members",
      "Take on challenging projects to gain experience"
    ],
    "skill_development": [],
    "company_targets": [
      "Mid-size companies with growth potential",
      "Startups in emerging industries",
      "Companies known for employee development"
    ],
    "networking": []
  }
}